Biodesix excels as a versatile business partner to pharma companies, offering cutting-edge multi-omic technologies for biomarker discovery, assay development, clinical sample testing and commercialization of diagnostic tests. We provide comprehensive end-to-end diagnostic services, serving industry giants, smaller businesses, and independent labs. With a proven track record of collaboration with over 60 companies and academic medical institutions, Biodesix’s adaptability and commitment to innovation make us an invaluable ally in advancing research and development of therapeutics for cancer and other diseases.
Click here for a list of our publications
Our technology platforms currently include:
- Droplet Digital™ PCR (ddPCR)
- Next Generation Sequencing (NGS)
- MALDI-ToF Mass Spectrometry
- Liquid Chromatography Mass Spectrometry (LC-MS)
- ELISA
Biomarker Assay Validation Capabilities:
- Research Use Only (RUO)
- Clinical Trial (CTA) or Investigational Use Only (IUO) Assays
- Companion Diagnostics (CDx)
Site |
Badges |
|
Biodesix
919 W. Dillon Rd
Louisville, CO, 80027
United States
|
|
|
Biodesix
919 W. Dillon Rd
Louisville, CO, 80027
United States
|
|
|
Biodesix - De Soto
8960 Commerce Dr #6
De Soto,, KS, 66018
United States
|
|